发明名称 |
MicroRNA compounds and methods for modulating miR-21 activity |
摘要 |
Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. |
申请公布号 |
US9267137(B2) |
申请公布日期 |
2016.02.23 |
申请号 |
US201514597676 |
申请日期 |
2015.01.15 |
申请人 |
Regulus Therapeutics Inc. |
发明人 |
Bhat Balkrishen;Marcusson Eric |
分类号 |
C12N15/11;C07H19/00;C12N15/113;A61K31/712;A61K45/06 |
主分类号 |
C12N15/11 |
代理机构 |
McNeill Baur PLLC |
代理人 |
McNeill Baur PLLC |
主权项 |
1. A compound comprising a modified oligonucleotide consisting of 12, 13, 14, or 15 linked nucleosides, wherein the nucleobase sequence of the modified oligonucleotide is complementary to miR-21 (SEQ ID NO: 1) and wherein the modified oligonucleotide comprises at least 12 contiguous nucleosides of the following nucleoside pattern VI in the 5′ to 3′ orientation:
NQ—NB—NB—NQ—(NB—NB—NQ—NQ)2—NB—NQ—NB wherein each NQ is a non-bicyclic nucleoside; and each NB is a bicyclic nucleoside. |
地址 |
San Diego CA US |